Sulfotransferase 1A3/4 copy number variation is associated with neurodegenerative disease.

Butcher, N J; Horne, M K; Mellick, G D; Fowler, C J; Masters, C L; Minchin, R F

Butcher, N J; Horne, M K; Mellick, G D; Fowler, C J; Masters, C L; Minchin, R F.

Affiliation

Butcher NJ; School of Biomedical Sciences, The University of Queensland, St Lucia, QLD, Australia.
Horne MK; Florey Institute, The University of Melbourne, Parkville, VIC, Australia.
Mellick GD; Eskitis Institute for Drug Discovery, Griffith University, Nathan, QLD, Australia.
Fowler CJ; Florey Institute, The University of Melbourne, Parkville, VIC, Australia.
Masters CL; Florey Institute, The University of Melbourne, Parkville, VIC, Australia.
Minchin RF; School of Biomedical Sciences, The University of Queensland, St Lucia, QLD, Australia.

Pharmacogenomics J ; 18(2): 209-214, 2018 04.

Article de En | MEDLINE | ID: mdl-28374858

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie de Parkinson / Arylsulfotransferase / Études d'associations génétiques / Variations de nombre de copies de segment d'ADN / Maladie d'Alzheimer Type d'étude: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Pharmacogenomics J Sujet du journal: BIOLOGIA MOLECULAR / FARMACOLOGIA Année: 2018 Type de document: Article Pays d'affiliation: Australie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google